These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 34896455)

  • 1. A flow-through chromatography purification process for Vero cell-derived influenza virus (H7N9).
    Fei C; Gao J; Fei C; Ma L; Zhu W; He L; Wu Y; Song S; Li W; Zhou J; Liao G
    J Virol Methods; 2022 Mar; 301():114408. PubMed ID: 34896455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downstream processing of Vero cell-derived human influenza A virus (H1N1) grown in serum-free medium.
    He C; Yang Z; Tong K
    J Chromatogr A; 2011 Aug; 1218(31):5279-85. PubMed ID: 21726872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 220 mutation in the hemagglutinin of avian influenza A (H7N9) virus alters antigenicity during vaccine strain development.
    Liu L; Lu J; Li Z; Zhou J; Guo J; Li X; Liu J; Shu Y; Wang D
    Hum Vaccin Immunother; 2018 Mar; 14(3):532-539. PubMed ID: 29300686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A fast and efficient purification platform for cell-based influenza viruses by flow-through chromatography.
    Tseng YF; Weng TC; Lai CC; Chen PL; Lee MS; Hu AY
    Vaccine; 2018 May; 36(22):3146-3152. PubMed ID: 28342667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human matriptase/ST 14 proteolytically cleaves H7N9 hemagglutinin and facilitates the activation of influenza A/Shanghai/2/2013 virus in cell culture.
    Whittaker GR; Straus MR
    Influenza Other Respir Viruses; 2020 Mar; 14(2):189-195. PubMed ID: 31820577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of mice and ferrets to a monovalent influenza A (H7N9) split vaccine.
    Duan Y; Gu H; Chen R; Zhao Z; Zhang L; Xing L; Lai C; Zhang P; Li Z; Zhang K; Wang Z; Zhang S; Wang X; Yang P
    PLoS One; 2014; 9(6):e99322. PubMed ID: 24937303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and protective efficacy of a Vero cell culture-derived whole-virus H7N9 vaccine in mice and guinea pigs.
    Wodal W; Schwendinger MG; Savidis-Dacho H; Crowe BA; Hohenadl C; Fritz R; Brühl P; Portsmouth D; Karner-Pichl A; Balta D; Grillberger L; Kistner O; Barrett PN; Howard MK
    PLoS One; 2015; 10(2):e0113963. PubMed ID: 25719901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of high-growth influenza H7N9 prepandemic candidate vaccine viruses in suspension MDCK cells.
    Tzeng TT; Chen PL; Weng TC; Tsai SY; Lai CC; Chou HI; Chen PW; Lu CC; Liu MT; Sung WC; Lee MS; Hu AY
    J Biomed Sci; 2020 Apr; 27(1):47. PubMed ID: 32241276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel approach for preparation of the antisera reagent for potency determination of inactivated H7N9 influenza vaccines.
    Schmeisser F; Jing X; Joshi M; Vasudevan A; Soto J; Li X; Choudhary A; Baichoo N; Resnick J; Ye Z; McCormick W; Weir JP
    Influenza Other Respir Viruses; 2016 Mar; 10(2):134-40. PubMed ID: 26616263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosylation generates an efficacious and immunogenic vaccine against H7N9 influenza virus.
    Kim JI; Park S; Bae JY; Lee S; Kim J; Kim G; Yoo K; Heo J; Kim YS; Shin JS; Park MS; Park MS
    PLoS Biol; 2020 Dec; 18(12):e3001024. PubMed ID: 33362243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Assessment of Fifth-Wave H7N9 Influenza A Viruses in Mammalian Models.
    Sun X; Belser JA; Pappas C; Pulit-Penaloza JA; Brock N; Zeng H; Creager HM; Le S; Wilson M; Lewis A; Stark TJ; Shieh WJ; Barnes J; Tumpey TM; Maines TR
    J Virol; 2019 Jan; 93(1):. PubMed ID: 30305359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification of cell culture-derived human influenza A virus by size-exclusion and anion-exchange chromatography.
    Kalbfuss B; Wolff M; Morenweiser R; Reichl U
    Biotechnol Bioeng; 2007 Apr; 96(5):932-44. PubMed ID: 16937411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of influenza A(H7N9) candidate vaccine viruses with improved hemagglutinin antigen yield in eggs.
    Ridenour C; Johnson A; Winne E; Hossain J; Mateu-Petit G; Balish A; Santana W; Kim T; Davis C; Cox NJ; Barr JR; Donis RO; Villanueva J; Williams TL; Chen LM
    Influenza Other Respir Viruses; 2015 Sep; 9(5):263-70. PubMed ID: 25962412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrophobic-interaction chromatography for purification of influenza A and B virus.
    Weigel T; Soliman R; Wolff MW; Reichl U
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jun; 1117():103-117. PubMed ID: 31005703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. African green monkey kidney (Vero) cells provide an alternative host cell system for influenza A and B viruses.
    Govorkova EA; Murti G; Meignier B; de Taisne C; Webster RG
    J Virol; 1996 Aug; 70(8):5519-24. PubMed ID: 8764064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic Drift of Influenza A(H7N9) Virus Hemagglutinin.
    Ning T; Nie J; Huang W; Li C; Li X; Liu Q; Zhao H; Wang Y
    J Infect Dis; 2019 Jan; 219(1):19-25. PubMed ID: 29982588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A recombinant H7N9 influenza vaccine with the H7 hemagglutinin transmembrane domain replaced by the H3 domain induces increased cross-reactive antibodies and improved interclade protection in mice.
    Wang Y; Wu J; Xue C; Wu Z; Lin Y; Wei Y; Wei X; Qin J; Zhang Y; Wen Z; Chen L; Liu GD; Cao Y
    Antiviral Res; 2017 Jul; 143():97-105. PubMed ID: 28408133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Single Amino Acid Substitution at Residue 218 of Hemagglutinin Improves the Growth of Influenza A(H7N9) Candidate Vaccine Viruses.
    Li X; Gao Y; Ye Z
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31270231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The stability and immunogenicity of inactivated MDCK cell-derived influenza H7N9 viruses.
    Tzeng TT; Lai CC; Weng TC; Cyue MH; Tsai SY; Tseng YF; Sung WC; Lee MS; Hu AY
    Vaccine; 2019 Nov; 37(47):7117-7122. PubMed ID: 31383484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant virus-like particles elicit protective immunity against avian influenza A(H7N9) virus infection in ferrets.
    Liu YV; Massare MJ; Pearce MB; Sun X; Belser JA; Maines TR; Creager HM; Glenn GM; Pushko P; Smith GE; Tumpey TM
    Vaccine; 2015 Apr; 33(18):2152-8. PubMed ID: 25772674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.